Le Cao

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Optical Coherence Tomography

Diabetic Retinopathy

Top Venues

Journal of the American Heart Association

Ophthalmology and therapy

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

William Robert Kwapong, Yuying Yan, Le Cao, Hang Wang, Chen Ye, Shuai Jiang, Wendan Tao, Bo Wu
Retinal Ischemic Perivascular Lesion Reflects Cerebral Small Vessel Disease Burden in Single Subcortical Infarction. Journal of the American Heart Association (2024)
William Robert Kwapong, Yuying Yan, Le Cao, Hang Wang, Chen Ye, Shuai Jiang, Wendan Tao, Bo Wu
Retinal Ischemic Perivascular Lesion Reflects Cerebral Small Vessel Disease Burden in Single Subcortical Infarction. Journal of the American Heart Association 13 (9) (2024)
William Robert Kwapong, Yuying Yan, Le Cao, Hang Wang, Chen Ye, Shuai Jiang, Wendan Tao, Bo Wu
Retinal Ischemic Perivascular Lesion Reflects Cerebral Small Vessel Disease Burden in Single Subcortical Infarction. Journal of the American Heart Association 13 (9) (2024)
Yujie Chen, Wei-Xi Xiong, Lu Lu, Xintong Wu, Le Cao, Jiani Chen, Yingfeng Xiao, Josemir W Sander, Bo Wu, Dong Zhou
The thickness of the retinal nerve fiber layer, macula, and ganglion cell-inner plexiform layer in people with drug-resistant epilepsy. Epilepsia open (2024)
Hang Wang, Le Cao, William Robert Kwapong, Guina Liu, Ruilin Wang, Junfeng Liu, Bo Wu
Optic Nerve Head Changes Measured by Swept Source Optical Coherence Tomography and Angiography in Patients with Intracranial Hypertension. Ophthalmology and therapy (2023)
Ruosu Pan, Chen Ye, Zhimeng Zhang, William Robert Kwapong, Ruilin Wang, Kun Lu, Lanhua Liao, Yuying Yan, Tang Yang, Le Cao, Shuai Jiang, Xuening Zhang, Junfeng Liu, Wendan Tao, Bo Wu
Distinct alterations of retinal structure between thalamic and extra-thalamic subcortical infarction patients: A cross-sectional and longitudinal study. CNS neuroscience & therapeutics (2023)